MPPW
ABBV icon

Mitchell & Pahl Private Wealth’s AbbVie ABBV Stock Holding History

Mitchell & Pahl Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.93M Buy
15,598
+309
+2% +$66.5K 1.44% 14
2026
Q1 		$3.33M Sell
15,289
-776
-5% -$172K 1.35% 15
2025
Q4 		$3.67M Sell
16,065
-224
-1% -$51K 1.52% 7
2025
Q3 		$3.77M Sell
16,289
-84
-0.5% -$17.1K 1.58% 4
2025
Q2 		$3.04M Buy
16,373
+410
+3% +$76.2K 1.34% 13
2025
Q1 		$3.34M Sell
15,963
-415
-3% -$80.7K 1.56% 9
2024
Q4 		$2.91M Buy
16,378
+588
+4% +$108K 1.36% 12
2024
Q3 		$3.12M Sell
15,790
-22
-0.1% -$4.11K 1.45% 12
2024
Q2 		$2.71M Sell
15,812
-162
-1% -$26.8K 1.43% 12
2024
Q1 		$2.91M Buy
15,974
+62
+0.4% +$10.7K 1.53% 12
2023
Q4 		$2.47M Sell
15,912
-649
-4% -$94.6K 1.4% 13
2023
Q3 		$2.47M Buy
16,561
+637
+4% +$93.5K 1.47% 13
2023
Q2 		$2.15M Buy
15,924
+257
+2% +$37.7K 1.29% 19
2023
Q1 		$2.5M Buy
15,667
+376
+2% +$57.5K 1.56% 11
2022
Q4 		$2.47M Buy
15,291
+2
+0% +$307 1.62% 11
2022
Q3 		$2.05M Buy
15,289
+292
+2% +$41.9K 1.52% 14
2022
Q2 		$2.3M Buy
14,997
+377
+3% +$57.6K 1.6% 11
2022
Q1 		$2.37M Buy
14,620
+180
+1% +$26.1K 1.51% 12
2021
Q4 		$1.96M Buy
14,440
+477
+3% +$56.3K 1.25% 20
2021
Q3 		$1.51M Buy
13,963
+108
+0.8% +$12.3K 1.08% 27
2021
Q2 		$1.56M Buy
13,855
+173
+1% +$19.5K 1.12% 26
2021
Q1 		$1.48M Buy
13,682
+320
+2% +$34.2K 1.15% 26
2020
Q4 		$1.43M Buy
+13,362
New +$1.28M 1.2% 23

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mitchell & Pahl Private Wealth's ABBV Position: Q2 2026 in Review

Mitchell & Pahl Private Wealth increased its AbbVie (ABBV) stake by 2% in Q2 2026, buying an estimated $66.5K and bringing the position to 15,598 shares worth $3.93M. The position accounts for 1.44% of the portfolio, ranked #14.

Mitchell & Pahl Private Wealth first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mitchell & Pahl Private Wealth held 15,598 shares of AbbVie worth $3.93M as of Q2 2026.
  • Mitchell & Pahl Private Wealth bought 309 AbbVie shares in Q2 2026, an estimated $66.5K.
  • AbbVie made up 1.44% of Mitchell & Pahl Private Wealth's portfolio in Q2 2026, its #14 holding.
  • Mitchell & Pahl Private Wealth first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mitchell & Pahl Private Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.